Related Experiment Video
Updated: Oct 9, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone
G E Kochiadakis1, E M Kanoupakis, M D Kalebubas
1Cardiology Department, Heraklion University Hospital, P.O. Box 1352, Stavrakia Heraklion, Crete, Greece.
Insights
Sotalol and metoprolol effectively lower heart rate in patients with chronic atrial fibrillation. Sotalol demonstrated superior heart rate control during submaximal exercise and daily activities compared to metoprolol.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Chronic atrial fibrillation (AF) management requires effective heart rate control.
- Digitalized patients with AF often present challenges in optimizing therapeutic interventions.
Purpose of the Study:
- To compare the efficacy of sotalol versus metoprolol in controlling heart rate.
- To assess heart rate responses during various activity levels, including isotonic exercise, isometric exercise, and daily life, in digitalized patients with chronic AF.
Main Methods:
- A randomized, single-blinded, crossover study involving 23 patients with chronic AF.
- Patients received placebo, sotalol, and metoprolol for 4-week periods.
- Assessments included 24-hour ECG monitoring, cardiopulmonary exercise testing, and isometric handgrip maneuvers.
Main Results:
- Both sotalol and metoprolol significantly reduced heart rate at rest and during isotonic exercise compared to placebo.
- Sotalol showed a significantly lower heart rate than metoprolol during submaximal exercise and isometric exercise.
- Sotalol also achieved a lower mean heart rate during daytime activities compared to metoprolol.
Conclusions:
- Sotalol is a safe and effective option for heart rate control in digitalized patients with atrial fibrillation.
- Sotalol offers superior heart rate control during submaximal exercise and daily activities compared to metoprolol.
Aims:
To compare the effects of sotalol and metoprolol on heart rate, during isotonic (ITE) and isometric (IME) exercise and daily activities, in digitalized patients with chronic atrial fibrillation.
Methods And Results:
The study had a randomized, single-blinded, crossover design. Twenty-three patients with chronic atrial fibrillation received placebo for 4 weeks, followed by a 4-week period of treatment with sotalol and metoprolol in random order. At the end of each period, the patients were assessed with 24-h ECG monitoring, a cardiopulmonary exercise test and a handgrip manoeuvre. Both agents produced a lower heart rate than placebo at rest and at all levels of isotonic exercise (P < 0.001) without affecting oxygen uptake. Sotalol produced a lower heart rate than metoprolol only at submaximal exercise (116 +/- 9 bpm for sotalol vs 125 +/- 11 bpm for metoprolol, P < 0.001). During isometric exercise, sotalol produced a lower maximum heart rate than did metoprolol (113 +/- 22 vs 129 +/- 18 bpm, respectively). Both agents produced a lower mean heart rate than placebo over 24 h (P < 0.001 for all), while sotalol produced a lower mean heart rate than metoprolol during the daytime (P < 0.01).
Conclusion:
Sotalol is a safe and effective agent for control of heart rate in digitalized patients with atrial fibrillation. Sotalol is superior to metoprolol at submaximal exercise, resulting in better rate control during daily activities.
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias IV: Characteristics of Bradyarrhythmias

